| Stage | SYK | % of rev | MMED | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.5B | 100.00% | $843M | 100.00% | SYK ×7.73 |
| Gross profit | $4.2B | 65.15% | $465M | 55.16% | SYK +10.0pp |
| Operating income | $1.0B | 15.86% | $5M | 0.59% | SYK +15.3pp |
| Pre-tax income | $997M | 15.29% | $4M | 0.47% | SYK +14.8pp |
| Net income | $753M | 11.55% | $0 | 0.00% | SYK +11.5pp |
| Stage | SYK | MMED | Gap · A − B |
|---|---|---|---|
| Revenue | $6.5B100.00% | $843M100.00% | SYK ×7.73 |
| Gross profit | 65.15%$4.2B | 55.16%$465M | SYK +10.0pp |
| Operating income | 15.86%$1.0B | 0.59%$5M | SYK +15.3pp |
| Pre-tax income | 15.29%$997M | 0.47%$4M | SYK +14.8pp |
| Net income |
| 11.55%$753M |
| 0.00%$0 |
| SYK +11.5pp |